Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery (DRY-CAT)
Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery: A Non- Interventional, Observational Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Eirini - Kanella Panagiotopoulou, MD, MSc, PhD
- Phone Number: +30 6978730858
- Email: panagiotopoulou.ek@gmail.com
Study Contact Backup
- Name: Georgios Labiris, MD, Prof
- Phone Number: +30 2551030990
- Email: labiris@usa.net
Study Locations
-
-
Evros
-
Alexandroupoli, Evros, Greece, 68100
- University Hospital of Alexandroupolis
-
Contact:
- Dimitrios Aggelonias, MSc
- Phone Number: +30 2551030990
- Email: dangelon@affil.duth.gr
-
Contact:
- Eirini - Kanella Panagiotopoulou
- Email: panagiotopoulou.ek@gmail.com
-
Principal Investigator:
- Eirini - Kanella Panagiotopoulou, MD, MSc, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Diagnosis of senile cataract with stage 2 or 3 nuclear opalescence according to the - Lens Opacities Classification System III (LOCS-3) grading scale
Exclusion Criteria:
- Former incisional surgery
- Former diagnosis of corneal disease
- Autoimmune diseases
- Mental diseases
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Study Group 1
Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)
|
Cataract patients will be administered Drops of Sodium Hyaluronate 0.15% and Dexpanthenol 2% quid in their postoperative regimen
|
|
Study Group 2
Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)
|
Cataract patients will be administered Drops of Sodium Hyaluronate 0.15% and Trehalose 3% quid in their postoperative regimen
|
|
Study Group 3
Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)
|
Cataract patients will be administered Drops of Sodium Hyaluronate 0.2% and Amino acids quid in their postoperative regimen
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ocular Surface Disease Index (OSDI)
Time Frame: 12 weeks
|
A subjective parameter that quantifies corneal discomfort
|
12 weeks
|
|
Tear Break-up Time (TBUT)
Time Frame: 12 weeks
|
An objective parameter that quantifies stability of tear film
|
12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Schirmer test (basal tear production)
Time Frame: 12 weeks
|
An objective test that assesses basal tear production alone using topical anesthetic drops, by removing the stimulus that triggers reflex tearing.
|
12 weeks
|
|
Efron scale for bulbar redness
Time Frame: 12 weeks
|
A clinical tool consisting of five photographic, color-calibrated images (graded 0 to 4) that allow practitioners to classify the severity of conjunctival hyperaemia, ranging from normal to severe Grade 0: Normal, pale eyelid margin, minimal conjunctival vessels.
Grade 1: Trace/Very Slight redness.
Grade 2: Slight/Mild redness.
Grade 3: Moderate redness.
Grade 4: Severe redness.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Georgios Labiris, MD, Prof, Democritus University of Thrace
Publications and helpful links
General Publications
- Labiris G, Ntonti P, Sideroudi H, Kozobolis V. Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study. Eye Vis (Lond). 2017 May 10;4:13. doi: 10.1186/s40662-017-0079-5. eCollection 2017.
- Ntonti P, Panagiotopoulou EK, Karastatiras G, Breyannis N, Tsironi S, Labiris G. Impact of 0.1% sodium hyaluronate and 0.2% sodium hyaluronate artificial tears on postoperative discomfort following cataract extraction surgery: a comparative study. Eye Vis (Lond). 2019 Feb 11;6:6. doi: 10.1186/s40662-019-0131-8. eCollection 2019.
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ES10/Th23/20-04-2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.